Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban

Prothrombin Time-International Normalized Ratio Predicts the Outcome of Atrial Fibrillation Patients Taking Rivaroxaban

Background: Although direct oral anticoagulants (DOACs) for patients with atrial fibrillation (AF) are considered to be safe, over or under anticoagulation and increased bleeding or thromboembolic risk are still considered individually. We aimed to investigate whether there is an association between...

Full description

Bibliographic Details
Main Authors: Tze-Fan Chao, Yi-Hsin Chan, Pei-Chien Tsai, Hsin-Fu Lee, Shang-Hung Chang, Chi-Tai Kuo, Gregory Y. H. Lip, Shih-Ann Chen, Yung-Hsin Yeh
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Biomedicines
Subjects:
atrial fibrillation
DOACs
prothrombin time
activated partial thromboplastin time
ischemic stroke
major bleeding
Online Access:https://www.mdpi.com/2227-9059/10/12/3210

Internet

https://www.mdpi.com/2227-9059/10/12/3210

Similar Items